Culture is still pharma’s biggest transformation bottleneck – what does it take to move from project thinking to product thinking?
- DiMe's Navigator: Why Teams Still Stall On Digital Endpoints
- Why Are Life Science Companies So Poorly Prepared For RIM's Future?
- Digital Endpoints Are Ready. Clinical Development Isn't
- Why Clinical Trial Data Cleaning Must Go Continuous (And How To Do It)
- What Clinical Analytics Solutions Are Shaping Clinical Research
- Sites Are Building Their Own Tech – SCRS On What That Means
- Human-In-The-Loop In AI Validation And Control: From Principle To Practice
- When The System Breaks, Who Pays? SCRS On Site Tech Gaps
ON-DEMAND WEBINARS
From eRecruitment, pre-screening, eConsent, and image-based data capture, explore how a decentralized trial design helps streamline enrollment, increase patient retention, and ensure data quality.
This on-demand webinar provides a thorough overview of why IQVIA Technologies is building One Home for Sites, how it works, and who should participate.
In this presentation, a distinguished panel of experts illuminates the crucial role of patient-reported outcomes (PROs) in shaping regulatory decisions and drug development strategies.
Discover how digital innovation and patient-centric technologies are reshaping clinical trials by improving access, efficiency, and data-driven insights.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![agenic-ai-GettyImages-2245878087]( "Agentic AI Is Transforming Life Sciences Discovery And Operations")
Agentic AI Is Transforming Life Sciences Discovery And Operations73% of pharma companies are planning or deploying agentic AI. Discover who’s leading and how intelligent agents are transforming R&D.
-
![GettyImages-1315159023 oncology ps]( "Addressing The Specific Complexities Of Oncology eCOA Clinical Trials")
Addressing The Specific Complexities Of Oncology eCOA Clinical TrialsWhat are the specific tools and keys to conduct eCOA trials in oncology successfully? This article identifies some of the relevant solutions to tackle oncology protocol complexities.
-
![Data time clock GettyImages-454148967]( "Why Now Is The Right Time To Adopt eConsent")
Why Now Is The Right Time To Adopt eConsentAs much as eConsent helps staff, participants are also likely to prefer it over traditional paper methods. Explore the benefits of eConsent and some strategic steps sites can take right now to adopt the process.
-
![GettyImages-1312649676 data lab]( "The Future Of Data Linkage In Clinical Trial Evidence Generation")
The Future Of Data Linkage In Clinical Trial Evidence GenerationExplore key questions about the future of AI and data linkage in clinical trial evidence generation.
-
![GettyImages-1418357455 data]( "A Few Clicks And Done: Automating EDC Data Entry")
A Few Clicks And Done: Automating EDC Data EntryA novel solution has emerged to tackle the inefficiency and errors in manual data re-entry during clinical trials, streamlining data entry, eliminate application switching, and benefit all stakeholders.
-
![Market-Trends-GettyImages-1349640220]( "ISR Report Sheds Light On eCOA/ePRO Market Dynamics")
ISR Report Sheds Light On eCOA/ePRO Market DynamicsThis comprehensive overview highlights the critical role these platforms play in modern clinical research, emphasizing their impact on data integrity and trial efficiency.
-
![sitees-GettyImages-1058161052]( "The Site-Sponsor Digital Divide Is Slowing Clinical Trial Innovation")
The Site-Sponsor Digital Divide Is Slowing Clinical Trial InnovationClinical trial site digitization often stalls due to operational, cultural, and structural barriers. Site-centered workflows can overcome these, boosting efficiency, visibility, and execution.
-
![GettyImages-1451854647 nurse data]( "2024: The Year Of EHR eSource In Clinical Trials")
2024: The Year Of EHR eSource In Clinical TrialsDiscover the power of EHR eSource in 2024—unlock 10 compelling reasons to elevate your approach and enhance clinical research outcomes.
-
![Sales Advice Data Analytics]( "Complex Randomization Delivered Successfully")
Complex Randomization Delivered SuccessfullyLearn about the strategy and successful execution of a complex randomization design that helped LG Chem overcome its clinical trial challenges alongside eClinical randomization experts.
-
![GettyImages-1313030664-doctor-office-tablet-futuristic-ai-connected]( "Do CROs Need To Reinvent Themselves In 2025?")
Do CROs Need To Reinvent Themselves In 2025?Facing economic pressures, regulatory changes, and technological advancements, CROs must redefine their value propositions and discuss the need for reinvention in 2025 to accelerate into the future.
RECENT NEWSLETTERS
- 05.14.26 -- AI, RWE, And The Systems Breaking Clinical Trials
- 05.07.26 -- How AI, ICH E6(R3) & RWD Are Reshaping Clinical Trials
- 05.02.26 -- Best Of April: AI In Clinical Trials — What Working
- 04.30.26 -- AI, RWE & Predictive Analytics Are Reshaping Trials
- 04.23.26 -- Smarter Trials Start Here: Data Quality, AI & Infrastructure Insights
